Christopher is the Global Head of Health Economics & Outcomes Research at Abbvie, an adjunct professor at NYU Graduate School of Public Service and active board member of several influential organizations. He has received numerous recognitions in the past. In 2019 he was named a Top 100 Innovator in Data Analytics, in 2018 an Emerging Pharma Leader and in 2017 he was a Top 40 Under 40 in Minority Health Honoree by the National Minority Quality Forum Christopher explains how, in his eyes, all human data is healthcare data, and how excited he is at the applications this data might have if we learned how to analyze it in a better way, given that, currently, only 5% of all the available data is being analyzed. Stay tuned to know how the broad array of experiences he had in organizations like non profits, government and pharmaceuticals helped him learn to think outside the box and gain a broader perspective. Quotes: "I'm just not feeling it, it's just not meaningful to me and I just want to help people. "In my eyes, all data is healthcare data." "I think that the problem that we have is we're still in a society where there's fear of the unknown and I also think that in some cases the system is set up to benefit folks from having a level of fragmentation even lack of data quality." "You also have to identify what is the benefit or value proposition for each of these individuals or groups within the organisation for them to really buy into it." Read the full episode summary here: Episode #130 Enjoy Christopher Boone in our “Bitesize Insights for Data-Driven Leaders” Series!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related